ABSTRACT
INTRODUCTION
The cost of a product refers to the measurable value of various factors of production used by business enterprises in order to produce goods and services in their area of activity (1) . In hospitals, "the cost of health care" is defined as "the measurable value of production factors used by each hospital in order to produce the health care pertaining to their specific areas of activity" (2) .
Cost analysis is one of the most important financial management tools used by management accounting systems. Hospitals are obliged to use the resources they own at least in an efficient and productive manner, in order to survive and to produce the desired value added. Costperformance analysis is a management tool that helps hospital administrators to plan how to offer maximum levels of qualitative and quantitative services to the public by employing their existing resources and to scrutinize service performance in practice (2) .
Despite the obvious significance of cost and performance analyses, many hospitals in Turkey do not conduct them, and costs are not employed as an input in decision-making. Hence, this paper is written in view of alleviating this shortcoming and shedding light on the importance of strategic planning for hospital administrations.
MATERIALS AND METHODS
Data from two hospitals, Istanbul Yedikule and Izmir Dr. Suat Seren Chest Disease and Thoracic Surgery Training and Research Hospitals, were used in this study, as their indirect costs (such as number of beds, number of inpatients, and number of staff) were close to each other in 2006, 2007, and 2008 , the years for which the researchers intended to conduct patient cost analysis. Hospital names were abbreviated as Hospitals A and B respectively. Research was based on numerical data collected for this purpose, and descriptive methods of analysis were used. Income per bed was calculated by dividing the income obtained from inpatients over a certain period of time to the number of serviceable beds. Income per patient, on the other hand, was calculated by dividing the income from inpatients to the total number of inpatients who were discharged or who died after having been hospitalized.
Cost per patient and per day may be defined as the daily medical cost occurring during the stay of one patient in the hospital because of his/her illness. It was calculated simply by dividing the amount of cost per patient admitted to hospital because of certain disease to the average time of hospital stay of inpatients with the same disease, and it is expressed in EUR. Univariate comparisons were conducted with χ2 tests. p<0.05 was accepted as significant.
1 Euro = 2,10 was calculated as TL.
RESULTS
A Training and research hospital are establishments operating with revolving funds, and a great majority of revolving fund incomes (95% and above) of chest disease and thoracic surgery training and research hospitals are obtained from the Social Security Organization (SSO) and through green-card holding patients. The payments for green-card holding patients are made from the budget of the Ministry of Health, the payments of patients affiliated with the SSO are made from the budget of SSO, and the payments of patients employed at public organizations with auxiliary budgets are made from the budgets of these organizations. Table 1) . The difference between the two was found as significant (p<0.0001). It was also revealed that in Hospital B, which is a specialized branch hospital in the area of chest diseases, while incomes derived from chest diseases decreased (from 50% down to 41.8%), incomes derived from branches other than chest diseases were on a gradual increase (Table 1 ).
In 2006, 11,677 inpatients were admitted to Hospital A, which had 419 beds, and 15,436 inpatients were admitted to Hospital B, which had 469 beds. The bed turnover rate in Hospital A was calculated as 27.7, and in Hospital B as 33.0. In 2007, however, the number of beds of Hospital A rose to 427, and 13,779 inpatients were admitted, in comparison to Hospital B, whose number of beds rose to 474, and to which 15,099 inpatients were admitted for treatment. In 2008, 16,324 inpatients were admitted by Hospital A with 425 beds, and 15,173 patients were admitted to Hospital B whose number of beds rose to 500. The bed turnover rate in Hospital A was 38.4 and in Hospital B it was 30.3 in 2008. While the number of inpatients increased by 1.7% and the bed turnover rate increased by 8.1% in Hospital B, which increased its number of beds by 6.6% between 2006 and 2008, in Hospital A the number of beds increased by 1.4%, the number of inpatients increased by 40.5%, and and it decreased gradually in Hospital A (from 11.6 days to 8.9 days). As such, one would expect that in Hospital A, given the increase in bed turnover rate, the decline in the average duration of stay, and the increase in the number of beds, the bed occupancy rate would increase and both the incomes per patient and per bed would be positively affected (Tables 2 and 3 ). However, even though there was a slight increase in incomes per bed, there was a slight decrease in incomes per patient. Table 3) .
As it can be followed from the above table, even though the incomes derived from patients admitted to the chest disease clinics of both hospitals did not decrease, their incomes per patient decreased gradually or they remained unchanged. Based on the comparison of costs of the two hospitals, it can be argued that Hospital B treated patients at lower costs than Hospital A, even though the difference was not found as significant. Given the fact that both hospitals are specialized branch hospitals, more than 2/3 of their inpatients were patients with lung cancer, chronic obstructive pulmonary disease (COPD), pneumonia, and tuberculosis (TB) ( Table 5 ). Percentages differed in the two hospitals, but lung cancer took the number one position, followed by COPD in the second position and on the rise. As it can and in Hospital B by 6.2%). In order to understand which diseases contributed to this decrease, hospitalization costs associated with the four diseases, for which admissions were highest, were compared (Tables 3 and 6 ). In Hospital A, patients with lung cancer were identified as having the highest cost per person, and patients with tuberculosis had the lowest cost per person. In Hospital B costs were similar, but patients with COPD had the highest cost per person.
In all the four disease groups, costs per inpatient decreased in 2007 compared to 2006, and they increased partially in 2008. Costs of Hospital A were significantly lower (p<0.0001) than the costs of Hospital B in 2007 (Table 6 ).
Costs per patient per day of patients admitted to Hospitals A and B during 2006 and 2007 because of the four disease groups are presented in Table 7 . As it can be observed from the Average time of hospital stay, which is one of the main factors affecting the cost per patient per day, was about 9-10 days for lung disease, COPD, and pneumonia in both Hospitals. The only difference was with tuberculosis. In Hospital A, patients with tuberculosis stayed for an average of 16-18 days, and in Hospital B, this duration was approximately twice as much (Table 8 ). The table shows that the difference in costs per tuberculosis patients between the two hospitals was due to the duration of stay. The differences in other patients were independent of the duration of stay as durations of stay did not vary between the two hospitals.
DISCUSSION
The two main groups of public hospitals in Turkey are State hospitals offering secondary health care and training and research hospitals offering tertiary health care. There are also specialized branch hospitals established solely for the treatment of certain diseases (such as (3, 4) .
Health economics strives to find ways for a rational utilization of limited resources. In this line of thought, our hospitals also need to be operated in a cost-effective manner. Thus, expenditures must be lowered as much as possible and incomes must be used efficiently. Even though the incomes of both hospitals increased in 2006-2008, the incomes they obtained from patients with chest diseases did not increase at the same rate over the same period of time. Consequently, incomes per bed and per patient of both hospitals declined or remained unchanged (Table 3) . A promising finding in terms of health economics was the fact that the expenditures for medical tests made by both hospitals were either partially reduced or they remained unchanged.
Income per patient, which is typically much higher in branches of surgery, is below the general average in hospitals and clinics for mental and nervous disorders, chest diseases, and physical therapy and rehabilitation, which require longer hospital stays. In tuberculosis wards in particular, given the fact that some TB patients do not have social security coverage and patients are required to stay on an average more than 20 days, income per patient is negligibly small. Taking into account that about 10-15% of the bed capacity of chest diseases hospitals are used by tuberculosis patients, income per bed of these hospitals is bound to come out as low. The loss incurred due to this needs to be balanced, bearing in mind that these hospitals operate as revolving fund establishments.
As the number of cases increased, total incomes, and more importantly net incomes, decreased significantly, on account of a steady rise in the use of medications and hospital materials. Another factor causing incomes to decline was the fact that hospitals were not able to invoice certain expenditures to the SSO, albeit the share of these uncovered expenditures were diminishing.
About 40% of incomes of the two hospitals was derived from the consumption of medications and hospital materials. The same overall percentage for Turkey is about 15% (4). The comparison of the figures over two years shows that the consumption of medications and hospital materials was on a steady rise. Hospital administrations need to research the reasons behind this and take necessary measures.
The fact that in both hospitals the numbers and the ratios of patients admitted for being diagnosed with the four diseases were similar to each other shows that the indications for hospitalization for both hospitals were also similar. (Table 7) . The reasons for this should be assessed by reviewing the lines of expenditure.
The cost per patient per day may be defined as the daily medical cost of a patient during his/her stay at the hospital due to a disease. This parameter is used when insurance companies make economic assessments of hospitals, and it is also utilized when calculating the total burden caused by a certain disease from the point of view of health economics (5) . The importance of cost per patient per day lies in the fact that it does not only indicate inpatient productivity by diseases when compared to the daily cost per bed, it also enables organizations making the payments to assess disease costs and to make their budgets accordingly. In both hospitals, patients with lung cancer and COPD were found to have the highest values for cost per patient/day. Given the direct relationship of both diseases with tobacco use and thus their significance as public health problems, this figure alone shows the immensity of their economic burden.
In conclusion, it was found that in both hospitals expenditures were carried out in a rational and efficient manner, and costs were reduced. Nevertheless, in view of the increasing number of patients with chronic diseases and the need to monitor and treat patients with tuberculosis for longer hospital stays, it can be argued that specialized branch hospitals can offer better, more modern, and efficient services, if their expenses are covered more effectively.
